Fulvestrant (Faslodex®) demonstrates clinical benefit in heavily pretreated postmenopausal women with advanced breast cancer:: a single-center experience.

被引：0
|
作者：
Franco, S
Perez, A
Tan-Chiu, E
Frankel, C
Vogel, C
机构：
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2003年 / 82卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
439
引用
收藏
页码：S105 / S105
页数：1
相关论文
共 50 条
  • [11] CLINICAL BENEFIT OF FULVESTRANT IN POSTMENOPAUSAL WOMEN WITH ADVANCED BREAST CANCER ACCORDING TO PRIOR THERAPY
    De Angelis, Carmine
    Cerillo, Ivana
    Ruocco, Raffaella
    Stanzione, Brigida
    Milano, Monica
    Gargiulo, Piera
    Lauria, Rossella
    Bruzzese, Dario
    Arpino, Grazia
    De Placido, Sabino
    BREAST, 2013, 22 : S44 - S44
  • [12] Fulvestrant (Faslodex®) is effective in postmenopausal women with visceral metastases (VM) In advanced breast cancer (ABC)
    Mauriac, L
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S96 - S96
  • [13] Fulvestrant (Faslodex™) in advanced breast cancer:: clinical experience from a Belgian cooperative study
    Neven, Patrick
    Paridaens, Robert
    Pelgrims, Gino
    Martens, Marc
    Bols, Alain
    Goeminne, Jean Charles
    Vindevoghel, Anita
    Demol, Jan
    Stragier, Barbara
    De Greve, Jacques
    Fontaine, Christel
    Van Den Weyngaert, Danielle
    Becquart, Dominique
    Borms, Marleen
    Cocquyt, Veronique
    Van den Broecke, Rudy
    Selleslags, Jean
    Awada, Ahmad
    Dirix, Luc
    Van Dam, Peter
    Azerad, Marie Agnes
    Vandenhoven, Guy
    Christiaens, Marie Rose
    Vergote, Ignace
    BREAST CANCER RESEARCH AND TREATMENT, 2008, 109 (01) : 59 - 65
  • [14] Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer according to body mass index
    Gevorgyan, A.
    Ganzinelli, M.
    Martinetti, A.
    Lo Vullo, S.
    Mariani, L.
    Festinese, F.
    Sottotetti, E.
    Ferrari, B.
    Galli, G.
    de Braud, F.
    Di Cosimo, S.
    ANNALS OF ONCOLOGY, 2015, 26 : 12 - 13
  • [15] Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer according to prior therapy.
    De Angelis, Carmine
    Cerillo, Ivana
    Ruocco, Raffaella
    Bruzzese, Dario
    Forestieri, Valeria
    Lauria, Rossella
    Stanzione, Brigida
    Paciolla, Immacolata
    De Laurentiis, Michelino
    De Placido, Sabino
    Arpino, Grazia
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [16] Fulvestrant (Faslodex™) in advanced breast cancer: clinical experience from a Belgian cooperative study
    Patrick Neven
    Robert Paridaens
    Gino Pelgrims
    Marc Martens
    Alain Bols
    Jean Charles Goeminne
    Anita Vindevoghel
    Jan Demol
    Barbara Stragier
    Jacques De Greve
    Christel Fontaine
    Danielle Van Den Weyngaert
    Dominique Becquart
    Marleen Borms
    Veronique Cocquyt
    Rudy Van Den Broecke
    Jean Selleslags
    Ahmad Awada
    Luc Dirix
    Peter Van Dam
    Marie Agnes Azerad
    Guy Vandenhoven
    Marie Rose Christiaens
    Ignace Vergote
    Breast Cancer Research and Treatment, 2008, 109 : 59 - 65
  • [17] Single center experience with alpelisib-fulvestrant in heavily pretreated women with HR(+), HER-2 (-) metastatic breast cancer.
    Tryfonopoulos, Dimitrios
    Tzouda, Vasiliki
    Zouki, Dionysia
    Kyriakidou, Athina
    Sarris, Evangelos
    Grivas, Anastasios
    Gouveris, Panagiotis
    Papaxoinis, George
    Demiri, Stamatina G.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [18] Clinical experience with fulvestrant in pretreated patients with advanced breast cancer.
    Menjon Beltran, S.
    Garcia Garcia, J., Sr.
    Gonzalez Flores, E.
    Conde Herrero, V.
    Gonzalez Jimenez, E., Sr.
    Gutierrez Lomas, V., Sr.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [19] Evidence of continued sensitivity to endocrine agents in postmenopausal women with advanced breast cancer progressing on fulvestrant ('Faslodex®')
    Vergote, I
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 288 - 288
  • [20] Fulvestrant in postmenopausal women with advanced breast cancer
    Bross, PF
    Baird, A
    Chen, G
    Jee, JM
    Lostritto, RT
    Morse, DE
    Rosario, LA
    Williams, GM
    Yang, PL
    Rahman, A
    Williams, G
    Pazdur, R
    CLINICAL CANCER RESEARCH, 2003, 9 (12) : 4309 - 4317
12345